NAC Update Issue: New Information
October 6, 2000
Much new research (some published only this year) suggests that N-acetylcysteine (NAC), or other treatments to restore abnormally low blood levels of glutathione, may be helpful in HIV infection and a number of other illnesses as well. For years NAC has been one of the most popular "alternative" treatments; the new information suggests that it deserves more medical and research attention, and might be an important treatment for some persons with HIV or AIDS:
This update was prompted by the publication last week of the full report of a trial conducted several years ago in San Francisco, by the Stanford University group led by Drs. Leonard A. and Leonore A. Herzenberg, both Ph.D., in the Department of Genetics. We were surprised at how much new information is available, and published this issue to inform our readers.
Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.